skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of the von Hippel-Lindau disease tumor suppressor gene

Journal Article · · Science (Washington, D.C.); (United States)
; ; ; ; ; ; ;  [1]; ; ; ; ; ; ; ; ; ;  [2]; ; more »; ; ; ; ;  [3]; ; ; ;  [4]; ; ;  [5];  [6] « less
  1. National Cancer Inst., Frederick, MD (United States)
  2. Program Resources, Inc./DynCorp, Frederick, MD (United States) National Cancer Inst., Frederick, MD (United States)
  3. National Cancer Inst., Bethesda, MD (United States)
  4. Cambridge Univ. (United Kingdom)
  5. Centre d'Etude du Polymorphisme Humain, Paris (France)
  6. Baylor College, Houston, TX (United States)

A gene discovered by positional cloning has been identified as the von Hippel-Lindau (VHL) disease tumor suppressor gene. A restriction fragment encompassing the gene showed rearrangements in 28 of 221 VHL kindreds. Eighteen of these rearrangements were due to deletions in the candidate gene, including three large nonoverlapping deletions. Intragenic mutations were detected in cell lines derived from VHL patients and from sporadic renal cell carcinomas. The VHL gene is evolutionarily conserved and encodes two widely expressed transcripts of approximately 6 and 6.5 kilobases. The partial sequence of the inferred gene product shows no homology to other proteins, except for an acidic repeat domain found in the procyclic surface membrane glycoprotein of Trypanosoma brucei. 17 refs., 4 figs. 1 tab.

OSTI ID:
6310456
Journal Information:
Science (Washington, D.C.); (United States), Vol. 260:5112; ISSN 0036-8075
Country of Publication:
United States
Language:
English